253 related articles for article (PubMed ID: 28110132)
1. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
Gupta S; Carmona R; Malvar J; Young G
Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
[TBL] [Abstract][Full Text] [Related]
2. Thrombophilia in sickle cell disease: the red cell connection.
Setty BN; Rao AK; Stuart MJ
Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
[TBL] [Abstract][Full Text] [Related]
3. Coagulation activation in sickle cell trait: an exploratory study.
Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
[TBL] [Abstract][Full Text] [Related]
4. Coagulation changes in individuals with sickle cell trait.
Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Schlegel R; Williamson P
Am J Hematol; 2002 Feb; 69(2):89-94. PubMed ID: 11835343
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant activity in patients with sickle cell trait.
Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
7. The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell disease.
Wijnberge M; Parmar K; Kesse-Adu R; Howard J; Cohen AT; Hunt BJ
Thromb Res; 2017 Oct; 158():113-120. PubMed ID: 28888622
[TBL] [Abstract][Full Text] [Related]
8. Early-onset indicators of a hypercoagulable state and clinical complications in a cohort of children with sickle cell trait.
Reggiani G; Boaro MP; Menzato F; De Bon E; Bertomoro A; Casonato A; Lucente F; Fortino C; Sartori M; Steffan A; Martella M; D'Agnolo M; Sainati L; Colombatti R
Pediatr Blood Cancer; 2024 Jun; 71(6):e30971. PubMed ID: 38553897
[TBL] [Abstract][Full Text] [Related]
9. Elevated hypercoagulability markers in hemoglobin SC disease.
Colella MP; de Paula EV; Machado-Neto JA; Conran N; Annichino-Bizzacchi JM; Costa FF; Olalla Saad ST; Traina F
Haematologica; 2015 Apr; 100(4):466-71. PubMed ID: 25596272
[TBL] [Abstract][Full Text] [Related]
10. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
[TBL] [Abstract][Full Text] [Related]
11. Differences in perioperative coagulation between Japanese and other ethnic groups undergoing laparoscopic cholecystectomy.
Iwade M; Iwade K; Nomura M; Ozaki M
Surg Endosc; 2003 Dec; 17(12):2012-5. PubMed ID: 14577027
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
13. Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria.
Ahmed SG; Kagu MB; Ibrahim UA; Bukar AA
Blood Transfus; 2015 Oct; 13(4):639-43. PubMed ID: 26057489
[TBL] [Abstract][Full Text] [Related]
14. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
15. Enhanced thrombin generation in children with sickle cell disease.
Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
[TBL] [Abstract][Full Text] [Related]
16. Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease.
Yee DL; Edwards RM; Mueller BU; Teruya J
Arch Pathol Lab Med; 2005 Jun; 129(6):760-5. PubMed ID: 15913424
[TBL] [Abstract][Full Text] [Related]
17. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?
Karlsson O; Jeppsson A; Hellgren M
Int J Obstet Anesth; 2014 Feb; 23(1):10-7. PubMed ID: 24342222
[TBL] [Abstract][Full Text] [Related]
18. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
19. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
Arkel YS; Paidas MJ; Ku DH
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
